Considering the cellular effects of a NEK6 lack on DNA damage and apoptosis, we suggest that future studies can explore NEK6 inhibitors as potential inducers of synthetic lethality in prostate cancer. This evidence concerns the gene NEK6 and Familial prostate cancer.